Skip to main content
. 2021 Nov 18;12:791322. doi: 10.3389/fphar.2021.791322

TABLE 1.

Baseline Characteristic and operative variables.

Variable No. (%) PCT<1 ng/ml (N = 574) PCT≥1 ng/ml (N = 311) p Value
PCT, median (IQR), ng/mL 0.13 (0.29, 0.59) 1.1 (1.0, 5.9) -
Gender, female 117 (20.4) 63 (20.3) 0.965
Age,mean (SD),yr 55.5 ± 11.6 57.5 ± 12.2 0.227
Hypertension 129 (22.5) 83 (26.7) 0.226
DM 59 (10.3) 46 (14.8) 0.048
Smoking history 238 (41.5) 125 (40.2) 0.714
Drinking history 184 (32.1) 91 (29.3) 0.391
Tumor number, multiple 89 (15.5) 62 (19.9) 0.094
Tumor size, >5 cm 231 (40.2) 164 (52.7) <0.001
Antivirus 209 (36.4) 107 (34.4) 0.632
HBV-DNA, ≥50IU/m 249 (43.4) 141 (45.3) 0.575
Cirrhosis 274 (47.7) 158 (50.8) 0.383
Portal hypertension 102 (17.8) 71 (22.8) 0.070
Ascites 54 (9.4) 46 (14.8) 0.016
Portal blocking time,>30min 133 (232.2) 80 (37.6) 0.396
Blood loss,>500 ml 113 (19.7) 102 (32.8) <0.001
Blood transfusion,>200 ml 103 (17.9) 107 (34.4) <0.001
Liver resection range, ≥3 segment 172 (30) 117 (37.6) 0.025
Peritoneoscope 16 (2.8) 8 (2.6) 0.851

Abbreviation: PCT: procalcitonin; SD, standard deviation; DM, diabeties mellitus.